Who owns Onyx Pharmaceuticals?

Key details on Onyx Pharmaceuticals (Ticker: ONXX)

Who owns Onyx Pharmaceuticals?

Is ONXX a good stock to own? Find out who bought Onyx Pharmaceuticals, who sold Onyx Pharmaceuticals (ONXX) stock, and who holds a large position in Onyx Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Cowen 21.50M $26.87M Sept. 30, 2013
BNP PARIBAS ARBITRAGE, SNC 11.01M $2.51B June 30, 2013
FMR 10.23M $888.31M June 30, 2013
JPMORGAN CHASE & CO 6.30M $546.64M June 30, 2013
SUSQUEHANNA INTERNATIONAL 5.27M $656.50M Sept. 30, 2013
T. Rowe Price Associates 4.94M $428.71M June 30, 2013
Barclays 4.24M $526.44M Sept. 30, 2013
Vanguard 3.38M $421.03M Sept. 30, 2013
Davidson Kempner Capital Management 3.15M $392.85M Sept. 30, 2013
HBK Investments 2.72M $339.02M Sept. 30, 2013
Wells Fargo & Company 2.34M $202.86M June 30, 2013
HAP Trading 2.31M $287.75M Sept. 30, 2013
D. E. Shaw & Co 2.24M $279.14M Sept. 30, 2013
Jefferies 2.18M $145.16M June 30, 2012
Farallon Capital Management 2.02M $251.83M Sept. 30, 2013
Arrowgrass Capital Partners 1.98M $246.49M Sept. 30, 2013
BlackRock Institutional Trust Company, N.A. 1.77M $220.27M Sept. 30, 2013
Pentwater Capital Management 1.71M $64.43M March 31, 2012
LORD, ABBETT & CO 1.69M $146.32M June 30, 2013
Palo Alto Investors 1.48M $131.15M March 31, 2013
Adage Capital Partners GP 1.46M $126.67M June 30, 2013
Jennison Associates 1.40M $121.87M June 30, 2013
Westchester Capital Management 1.37M $170.32M Sept. 30, 2013
BlackRock Fund Advisors 1.36M $169.37M Sept. 30, 2013
Sectoral Asset Management 1.36M $117.73M June 30, 2013
Frontier Capital Management 1.32M $114.69M June 30, 2013
ALLIANCEBERNSTEIN 1.26M $109.09M June 30, 2013
PointState Capital 1.24M $82.46M June 30, 2012
Franklin Resources 1.21M $104.87M June 30, 2013
STATE STREET CORPORATION 1.20M $149.85M Sept. 30, 2013
OrbiMed Advisors 1.18M $102.01M June 30, 2013
Inves 1.17M $103.66M March 31, 2013
Bank of America Corporation 1.16M $145.21M Sept. 30, 2013
Wellington Management Company 1.16M $144.83M Sept. 30, 2013
Columbia Wanger Asset Management 1.13M $97.85M June 30, 2013
P. SCHOENFELD ASSET MANAGEMENT 1.10M $137.17M Sept. 30, 2013
S.A.C. Capital Advisors 1.08M $47.30M Dec. 31, 2011
Bridger Management 1.07M $47.25M Dec. 31, 2011
TimesSquare Capital Management 1.06M $39.79M March 31, 2012
Oracle Investment Management 1.05M $69.48B June 30, 2012
Ameriprise Financial 1.03M $68.43M June 30, 2012

Who sold Onyx Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
CITADEL ADVISORS Sept. 30, 2011 1.43M $42.94M
Ridgeback Capital Investments March 31, 2011 1.62M $57.08M
Visium Asset Management Dec. 31, 2010 1.33M $48.86M
Lone Pine Capital Sept. 30, 2006 2.39M $41.27M
Maverick Capital March 31, 2006 1.70M $44.67M